FDA-话题@MedSci

#FDA#

54篇内容 | 14364人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2235787, encodeId=cfdc2235e8786, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=9b341210e116' target=_blank style='color:#2F92EE;'>#罕见病创新中心#</a>, objectTitle=FDA 新罕见病创新中心，加强协作和监管灵活性成为两大关注点, objectType=article, longId=850206, objectId=17448502065c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241105/1730783707634_8538692.jpg, objectUrl=/article/show_article.do?id=17448502065c, replyNumber=0, likeNumber=26, createdTime=2024-11-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17448502065c, moduleTitle=FDA 新罕见病创新中心，加强协作和监管灵活性成为两大关注点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17448502065c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234147, encodeId=13f7223414e69, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=61888e8231b' target=_blank style='color:#2F92EE;'>#药物相互作用#</a>, objectTitle=FDA 发布药物相互作用标签指南草案, objectType=article, longId=849049, objectId=b3ee84904946, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240617/1718612054574_5579292.jpg, objectUrl=/article/show_article.do?id=b3ee84904946, replyNumber=0, likeNumber=31, createdTime=2024-10-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b3ee84904946, moduleTitle=FDA 发布药物相互作用标签指南草案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ee84904946)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214402, encodeId=6e62221440244, content=<a href='/topic/show?id=424833981d6' target=_blank style='color:#2F92EE;'>#医史钩沉#</a><a href='/topic/show?id=21d764465c7' target=_blank style='color:#2F92EE;'>#沙利度胺#</a><a href='/topic/show?id=793511651882' target=_blank style='color:#2F92EE;'>#药害#</a><a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>, objectTitle=医史钩沉：史上很大药害事件背后的女英雄，顶住上亿人的压力，她拯救了一个国家, objectType=article, longId=88300, objectId=7cbc8830051, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201702/20170204223316346.jpeg, objectUrl=/article/show_article.do?id=7cbc8830051, replyNumber=0, likeNumber=154, createdTime=2024-07-11, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=7cbc8830051, moduleTitle=医史钩沉：史上很大药害事件背后的女英雄，顶住上亿人的压力，她拯救了一个国家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cbc8830051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2212112, encodeId=23432212112d2, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=f5885086f1' target=_blank style='color:#2F92EE;'>#COPD#</a> <a href='/topic/show?id=4a82680e6f' target=_blank style='color:#2F92EE;'>#ensifentrine#</a>, objectTitle=FDA批准PDE3/4抑制剂ensifentrine用于成人COPD的维持治疗，这是首个吸入式疗法, objectType=article, longId=832229, objectId=ad88832229e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719557460080_4754896.png, objectUrl=/article/show_article.do?id=ad88832229e5, replyNumber=0, likeNumber=158, createdTime=2024-06-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=ad88832229e5, moduleTitle=FDA批准PDE3/4抑制剂ensifentrine用于成人COPD的维持治疗，这是首个吸入式疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad88832229e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208051, encodeId=1d08220805116, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=1b27120e0ed' target=_blank style='color:#2F92EE;'>#Moderna#</a> <a href='/topic/show?id=322b109294d6' target=_blank style='color:#2F92EE;'>#呼吸道合胞病毒（RSV）#</a> <a href='/topic/show?id=419a105085b1' target=_blank style='color:#2F92EE;'>#RSV疫苗#</a> <a href='/topic/show?id=5bff108e41d2' target=_blank style='color:#2F92EE;'>#mRNA-1345#</a>, objectTitle=FDA批准全球首个RSV mRNA疫苗mRESVIA（mRNA-1345）上市, objectType=article, longId=828655, objectId=5fb68286550a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240529/1347f5f21e6248b2a04299ec72db4c30-8rqIfWU9IVB5.jpg, objectUrl=/article/show_article.do?id=5fb68286550a, replyNumber=0, likeNumber=139, createdTime=2024-06-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=5fb68286550a, moduleTitle=FDA批准全球首个RSV mRNA疫苗mRESVIA（mRNA-1345）上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fb68286550a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2204276, encodeId=407b22042e673, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=73d4425e0cb' target=_blank style='color:#2F92EE;'>#复发或难治性多发性骨髓瘤#</a> <a href='/topic/show?id=85fa10446166' target=_blank style='color:#2F92EE;'>#西达基奥仑赛#</a>, objectTitle=CLIN CANCER RES | FDA批准摘要：西达基奥仑赛治疗复发或难治性多发性骨髓瘤, objectType=article, longId=825535, objectId=5b99825535a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240512/1715493300929_6145188.png, objectUrl=/article/show_article.do?id=5b99825535a3, replyNumber=0, likeNumber=96, createdTime=2024-05-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b99825535a3, moduleTitle=CLIN CANCER RES | FDA批准摘要：西达基奥仑赛治疗复发或难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b99825535a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197105, encodeId=9466219e10517, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>, objectTitle=FDA：3月新批准肿瘤药物汇总, objectType=article, longId=820349, objectId=2aef8203499e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393774192_4754896.jpeg, objectUrl=/article/show_article.do?id=2aef8203499e, replyNumber=0, likeNumber=105, createdTime=2024-04-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=2aef8203499e, moduleTitle=FDA：3月新批准肿瘤药物汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aef8203499e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195582, encodeId=8cbc21955827e, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>, objectTitle=JAMA评论：FDA 成为科学、政治焦点, objectType=article, longId=818068, objectId=b0cb818068d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240326/1711483628584_4754896.png, objectUrl=/article/show_article.do?id=b0cb818068d8, replyNumber=0, likeNumber=96, createdTime=2024-03-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=b0cb818068d8, moduleTitle=JAMA评论：FDA 成为科学、政治焦点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0cb818068d8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193147, encodeId=a25c219314efc, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>, objectTitle=这十款药物，今年有望获FDA批准！, objectType=article, longId=816980, objectId=c77e8169805d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240305/8edf22362f214013a9b4786c3b536474-CI6ZqK944SWz.jpg, objectUrl=/article/show_article.do?id=c77e8169805d, replyNumber=0, likeNumber=92, createdTime=2024-03-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=c77e8169805d, moduleTitle=这十款药物，今年有望获FDA批准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c77e8169805d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192919, encodeId=b4682192919a3, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=3bb5448299b' target=_blank style='color:#2F92EE;'>#妊娠#</a> <a href='/topic/show?id=ac4f3996e0f' target=_blank style='color:#2F92EE;'>#哺乳期#</a>, objectTitle=FDA妊娠与哺乳期标示规则(PLLR), objectType=article, longId=816928, objectId=2fa5816928f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696891216554_4754896.jpeg, objectUrl=/article/show_article.do?id=2fa5816928f7, replyNumber=0, likeNumber=99, createdTime=2024-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2fa5816928f7, moduleTitle=FDA妊娠与哺乳期标示规则(PLLR), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fa5816928f7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188169, encodeId=054f21881697b, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a> <a href='/topic/show?id=d23b11133e2b' target=_blank style='color:#2F92EE;'>#伊立替康脂质体#</a>, objectTitle=FDA批准伊立替康脂质体获批用于一线治疗转移性胰腺癌, objectType=article, longId=813885, objectId=f3be81388590, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240218/2f90de26e79d44af87fdacdfb127a102.jpg, objectUrl=/article/show_article.do?id=f3be81388590, replyNumber=1, likeNumber=118, createdTime=2024-02-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=f3be81388590, moduleTitle=FDA批准伊立替康脂质体获批用于一线治疗转移性胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3be81388590)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183204, encodeId=35762183204cf, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>, objectTitle=39年来FDA批准的1291款新药汇总, objectType=article, longId=810488, objectId=c510810488ac, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240118/a3a2dc82767946288f8cb80002192bcf.jpg, objectUrl=/article/show_article.do?id=c510810488ac, replyNumber=0, likeNumber=121, createdTime=2024-01-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=c510810488ac, moduleTitle=39年来FDA批准的1291款新药汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c510810488ac)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2178525, encodeId=766521e852520, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>, objectTitle=2023年度FDA审批69种创新药物上市, objectType=article, longId=807746, objectId=74b880e746a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231231/1704062698075_4754896.png, objectUrl=/article/show_article.do?id=74b880e746a3, replyNumber=0, likeNumber=118, createdTime=2024-01-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=74b880e746a3, moduleTitle=2023年度FDA审批69种创新药物上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b880e746a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176842, encodeId=2df221e684200, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a> <a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a> <a href='/topic/show?id=3ecb5564852' target=_blank style='color:#2F92EE;'>#抗肿瘤新药#</a>, objectTitle=一图汇总！2023年FDA批准的抗肿瘤新药及适应症, objectType=article, longId=806617, objectId=c3ff80661eae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231222/c902650219fa415ca1d30f061bce7b44.jpg, objectUrl=/article/show_article.do?id=c3ff80661eae, replyNumber=0, likeNumber=158, createdTime=2023-12-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=c3ff80661eae, moduleTitle=一图汇总！2023年FDA批准的抗肿瘤新药及适应症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3ff80661eae)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2163924, encodeId=7f052163924ae, content=美国<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准破坏肿瘤细胞的<a href='/topic/show?id=af4310e1562a' target=_blank style='color:#2F92EE;'>#声波治疗#</a>癌症，无创分解肿瘤病灶、复发率低！, objectTitle=非科幻小说，美国FDA批准破坏肿瘤细胞的声波治疗癌症，无创分解肿瘤病灶、复发率低！, objectType=article, longId=796909, objectId=8279e96909da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=8279e96909da, replyNumber=0, likeNumber=157, createdTime=2023-10-20, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8279e96909da, moduleTitle=非科幻小说，美国FDA批准破坏肿瘤细胞的声波治疗癌症，无创分解肿瘤病灶、复发率低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8279e96909da)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2162826, encodeId=2f88216282650, content=<a href='/topic/show?id=d50d1069e19b' target=_blank style='color:#2F92EE;'>#FDA进口警报#</a>：美国<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>拒绝进口中国食品及其主要原因，附<a href='/topic/show?id=ff721069e200' target=_blank style='color:#2F92EE;'>#绿名单#</a>公司<a href='/topic/show?id=80f2100958bb' target=_blank style='color:#2F92EE;'>#食品安全#</a> 一句话食品安全不容忽视, objectTitle=FDA进口警报：美国FDA拒绝进口中国食品及其主要原因，附绿名单公司（2023年第3季度）, objectType=article, longId=796193, objectId=a327e96193ba, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017045981_4754896.png, objectUrl=/article/show_article.do?id=a327e96193ba, replyNumber=0, likeNumber=125, createdTime=2023-10-15, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a327e96193ba, moduleTitle=FDA进口警报：美国FDA拒绝进口中国食品及其主要原因，附绿名单公司（2023年第3季度）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a327e96193ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2160981, encodeId=c37c21609819d, content=<a href='/topic/show?id=b5f71041887c' target=_blank style='color:#2F92EE;'>#ADC类药物#</a><a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>, objectTitle=mAbs：ADC类药物的临床蓝图, objectType=article, longId=794552, objectId=8e5be9455216, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230930/04970698b37840a2b7d0bfe546370b56.jpg, objectUrl=/article/show_article.do?id=8e5be9455216, replyNumber=0, likeNumber=106, createdTime=2023-10-05, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8e5be9455216, moduleTitle=mAbs：ADC类药物的临床蓝图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5be9455216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2147090, encodeId=d195214e090ba, content=美国<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准<a href='/topic/show?id=b0f710640492' target=_blank style='color:#2F92EE;'>#Livmarli#</a>治疗<a href='/topic/show?id=706b105e5925' target=_blank style='color:#2F92EE;'>#Alagille综合征#</a>(ALGS)相关<a href='/topic/show?id=0eff106405c9' target=_blank style='color:#2F92EE;'>#胆汁淤积性瘙痒#</a>的药物!, objectTitle=美国FDA批准Livmarli治疗Alagille综合征(ALGS)相关胆汁淤积性瘙痒的药物!, objectType=article, longId=780870, objectId=1e6be80870d6, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/webeditor/uploadfile/202110/20211012025836865.png, objectUrl=/article/show_article.do?id=1e6be80870d6, replyNumber=0, likeNumber=162, createdTime=2023-07-09, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1e6be80870d6, moduleTitle=美国FDA批准Livmarli治疗Alagille综合征(ALGS)相关胆汁淤积性瘙痒的药物!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e6be80870d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2092798, encodeId=81082092e98f3, content=美国食品和药物管理局（<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>）批准了礼来和 Incyte 公司开发的用于治疗成人<a href='/topic/show?id=015c5e95173' target=_blank style='color:#2F92EE;'>#斑秃#</a>的口服药物 <a href='/topic/show?id=7fa8104913ea' target=_blank style='color:#2F92EE;'>#JAK 抑制剂#</a><a href='/topic/show?id=00664830602' target=_blank style='color:#2F92EE;'>#巴瑞替尼#</a>（<a href='/topic/show?id=e55a3203bc' target=_blank style='color:#2F92EE;'>#baricitinib#</a>）。这也是 FDA 首次批准治疗斑秃的全身性系统疗法（而非身体的特定部位）。, objectTitle=NEJM：可恢复80%头发生长，FDA批准首款口服抗脱发新药上市, objectType=article, longId=729601, objectId=94b7e29601db, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220615/1655261533816_5295905.jpg, objectUrl=/article/show_article.do?id=94b7e29601db, replyNumber=1, likeNumber=155, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94b7e29601db, moduleTitle=NEJM：可恢复80%头发生长，FDA批准首款口服抗脱发新药上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94b7e29601db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2140711, encodeId=b7d22140e1196, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>已批准<a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a><a href='/topic/show?id=0daf39e120a' target=_blank style='color:#2F92EE;'>#呼吸道合胞病毒#</a>（RSV）二价<a href='/topic/show?id=419a105085b1' target=_blank style='color:#2F92EE;'>#RSV疫苗#</a> <a href='/topic/show?id=dd0d1063109e' target=_blank style='color:#2F92EE;'>#Abrysvo#</a>（RSVpreF，PF-06928316）上市，未来会竞争十分激烈, objectTitle=FDA已批准辉瑞呼吸道合胞病毒（RSV）二价疫苗 Abrysvo（RSVpreF，PF-06928316）上市, objectType=article, longId=775173, objectId=bbfee7517321, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230603/77e7153aca4749b4b1c18c92d4ee87da.jpg, objectUrl=/article/show_article.do?id=bbfee7517321, replyNumber=0, likeNumber=171, createdTime=2023-06-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bbfee7517321, moduleTitle=FDA已批准辉瑞呼吸道合胞病毒（RSV）二价疫苗 Abrysvo（RSVpreF，PF-06928316）上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbfee7517321)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA

2020-05-29发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #罕见病创新中心#

FDA 新罕见病创新中心，加强协作和监管灵活性成为两大关注点

2024-11-07发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #药物相互作用#

FDA 发布药物相互作用标签指南草案

2024-10-30发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#医史钩沉##沙利度胺##药害##FDA#

医史钩沉：史上很大药害事件背后的女英雄，顶住上亿人的压力，她拯救了一个国家

2024-07-11发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #COPD# #ensifentrine#

FDA批准PDE3/4抑制剂ensifentrine用于成人COPD的维持治疗，这是首个吸入式疗法

2024-06-28发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #Moderna# #呼吸道合胞病毒（RSV）# #RSV疫苗# #mRNA-1345#

FDA批准全球首个RSV mRNA疫苗mRESVIA（mRNA-1345）上市

2024-06-03发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #复发或难治性多发性骨髓瘤# #西达基奥仑赛#

CLIN CANCER RES | FDA批准摘要：西达基奥仑赛治疗复发或难治性多发性骨髓瘤

2024-05-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA#

FDA：3月新批准肿瘤药物汇总

2024-04-06发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA#

JAMA评论：FDA 成为科学、政治焦点

2024-03-27发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA#

这十款药物，今年有望获FDA批准！

2024-03-14发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#FDA# #妊娠# #哺乳期#

FDA妊娠与哺乳期标示规则(PLLR)

2024-03-13发表于上海

梅斯管理员 (审核中...)